Senturk, HAKANBaysal, BirolTahan, VeyselZerdali, HasanOzaras, ResatTabak, FehmiMert, AliCanbakan, BillurTabak, OmurOzbay, Gulsen2021-01-192021-01-192011-01-01Senturk H., Baysal B., Tahan V., Zerdali H., Ozaras R., Tabak F., Mert A., Canbakan B., Tabak O., Ozbay G., -Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection-, DIGESTIVE DISEASES AND SCIENCES, cilt.56, ss.208-212, 2011http://hdl.handle.net/20.500.12645/28016Introduction Several studies have reported that interferon therapy increases elimination rate of HBeAg and anti-HBe seroconversion in chronic hepatitis B (CHB) patients. We aimed to evaluate long-term results of interferon-alpha treatment in HBeAg positive CHB patients in a country with exclusively D genotype.Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B InfectionArticleWOS:0002860059000287915147510110.1007/s10620-010-1255-9